Tears may reveal best glaucoma treatment

NCT ID NCT07592988

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examines tear fluid for signs of inflammation in people with glaucoma who receive different treatments. Researchers will measure certain proteins in tears and eye pressure before and after treatment. The goal is to see if these tear markers can predict how well a treatment works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors choose the best glaucoma treatment based on tear fluid markers.

What could go wrong

This is a small, early study with only 24 participants, so results may not apply to everyone. It is designed to gather knowledge, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kazakh Eye Research Institute

    RECRUITING

    Almaty, 050012, Kazakhstan

    Contact Phone: •••-•••-•••• Email: •••••@•••••